CATALAYER NEWS
Praxis claims efficacy success in phase 2 seizure trial, setting up approval talks with FDA - Fierce Biotech
Source: Fierce Biotech · 2025-12-05
Full article text is available in the Catalayer news terminal.
RELATED ON CATALAYER
Related Topics
Biotech & FDA NewsRELATED MARKETS
Prediction Markets